These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1330237)

  • 1. Calcium regulating activity of 26,27-dialkyl analogs of 1 alpha,25-dihydroxyvitamin D3.
    Miyahara T; Harada M; Miyata M; Sugure A; Ikemoto Y; Takamura T; Higuchi S; Otomo S; Kozuka H; Ikekawa N
    Calcif Tissue Int; 1992 Sep; 51(3):218-22. PubMed ID: 1330237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
    Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium regulating activity of 26,27-dimethyl analog of 24R,25-dihydroxyvitamin D3.
    Miyahara T; Harada M; Kondo S; Komiyama H; Matsuda S; Miyanishi A; Matsumoto M; Xue-Ya W; Ikemoto Y; Sugure A
    Calcif Tissue Int; 1994 Sep; 55(3):190-7. PubMed ID: 7987732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on carbon lengthening at the side chain terminal of 1 alpha,25-dihydroxyvitamin D3 for calcium regulating activity.
    Eguchi T; Ikekawa N; Sumitani K; Kumegawa M; Higuchi S; Otomo S
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1246-9. PubMed ID: 2168297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elongation of the side chain of analogs of 1 alpha,25-dihydroxyvitamin D3 prevents osteopenia in a rat model.
    Harada M; Takamura T; Kajita-Kondo S; Kozakai A; Miyahara T; Kozuka H; Ikekawa N; Higuchi S; Otomo S
    Calcif Tissue Int; 1995 Mar; 56(3):220-6. PubMed ID: 7750028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F; Mayer E; Norman AW
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
    Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3.
    Hara N; Eguchi T; Ikekawa N; Ishizuka S; Sato J
    J Steroid Biochem; 1990 May; 35(6):655-64. PubMed ID: 2163469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships.
    Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of 1 alpha,23,25,26-tetrahydroxyvitamin D3.
    Ishizuka S; Reichel H; Norman AW
    Arch Biochem Biophys; 1987 Apr; 254(1):188-95. PubMed ID: 3034157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro.
    Stern PH; Mavreas T; Tanaka Y; DeLuca HF; Ikekawa N; Kobayashi Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):9-13. PubMed ID: 6323693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
    Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y; Kumegawa M
    Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity assessment of the vitamin D metabolites 1,25-dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3.
    Mayer E; Bishop JE; Ohnuma N; Norman AW
    Arch Biochem Biophys; 1983 Jul; 224(2):671-6. PubMed ID: 6307158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
    Sato K; Nishii Y; Woodiel FN; Raisz LG
    Bone; 1993; 14(1):47-51. PubMed ID: 8443002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on two new vitamin D analogs, EB 1089 and KH 1060: effects on bone resorption and osteoclast recruitment in vitro.
    Wiberg K; Ljunghall S; Binderup L; Ljunggren O
    Bone; 1995 Oct; 17(4):391-5. PubMed ID: 8573413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 26,27-Hexafluoro-1,25-dihydroxyvitamin D3 (F6-1,25(OH)2D3) prevents osteoporosis induced by immobilization combined with ovariectomy in the rat.
    Okumura H; Yamamuro T; Higuchi S; Harada M; Takamura T; Otomo S; Aihara H; Ikekawa N; Kobayashi T
    Bone Miner; 1990 May; 9(2):101-9. PubMed ID: 2350614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone in the rat.
    Ishizuka S; Ishimoto S; Norman AW
    J Steroid Biochem; 1984 Feb; 20(2):611-5. PubMed ID: 6323873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of novel vitamin D analogues: 24,24-difluoro-25-hydroxy-26,27-dimethylvitamin D3 and 24,24-difluoro-1 alpha,25-dihydroxy-26,27-dimethylvitamin D3.
    Gill HS; Londowski JM; Corradino RA; Zinsmeister AR; Kumar R
    J Med Chem; 1990 Feb; 33(2):480-90. PubMed ID: 2153815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.